Table 2 Treatments of ANCA-associated vasculitis complicated with thymoma (review)
From: Microscopic polyangiitis associated with thymic tumor: a case report and review of the literature
No. | authors | year | thymectomy | thymic pathology | medication for vasculitis | outcome | ||||
|---|---|---|---|---|---|---|---|---|---|---|
findings | class | CS | CYC | others | remission | relapse | ||||
1 | Haberhauer G, et al. | 1993 | done | hyperplasia |  | + | – | NSAID | CR | relapse |
2 | Kobayashi M, et al. | 1995 | done | non-invasive | B2 | 30 mg/d | – | G-CSFa | CRa | none |
3 | Valli G, et al. | 1998 | done | NA | NA | + | + | – | ESRD | NA |
4 | Karras A, et al. | 2005 | done | non-invasive | B2 | + | – | AZA | CR | NA |
5 | Karras A, et al. | 2005 | not done |  |  | + | – | – | PR | NA |
6 | Parambil JG, et al. | 2006 | done | non-invasive | B2 | 1.0 mg/kg/d | 2.0 mg/kg/d | AZA | CR | none |
7 | Holmes MV, et al. | 2007 | done | invasive | B1 | + | + | – | CR | NA |
8 | The present case | 2018 | not done |  |  | 1.0 mg/kg/d | – | Rituximab | ESRD | none |